---
schema_version: "secwatch.filing_event.v1"
accession: "0001683168-25-002874"
form_type: "8-K"
ticker: "SNOA"
cik: "0001367083"
company_name: "Sonoma Pharmaceuticals, Inc."
filed_at: "2025-04-28T23:59:59+00:00"
generated_at: "2026-05-23T04:49:18.365595+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.2
calibrated_materiality_score: 0.2
confidence: "low"
source: SEC EDGAR
---

# Sonoma Pharmaceuticals files updated investor presentation; no specific new data in excerpt

## Summary
- Company filed an updated investor presentation as of April 28, 2025, under Item 8.01.
- The excerpt provided contains only legal disclaimers and forward-looking language; no operational or financial updates are visible.
- No changes to strategy, guidance, or product pipeline can be extracted from the available text.

## SEC filing metadata
- accession: 0001683168-25-002874
- form_type: 8-K
- ticker: SNOA
- cik: 0001367083
- company_name: Sonoma Pharmaceuticals, Inc.
- filed_at: 2025-04-28T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.2
- calibrated_materiality_score: 0.2
- confidence: low
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1367083/000168316825002874/0001683168-25-002874-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1367083/000168316825002874/sonoma_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001683168-25-002874
- JSON: https://secwatch.observer/filing/0001683168-25-002874.json
- Plain text: https://secwatch.observer/filing/0001683168-25-002874.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.